Technology
Health
Pharmaceutical

Pacira BioSciences

$39.56
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.32 (-0.80%) As of 10:22 AM EDT today
-$0.32 (-0.80%) Today

Why Robinhood?

You can buy or sell PCRX and other stocks, options, ETFs, and crypto commission-free!

About PCRX

Pacira Biosciences, Inc. operates as a holding company, which engages in the development, commercialization, and manufacture of pharmaceutical products for use in postsurgical outcomes for acute care practitioners and their patients. Its flagship product, EXPAREL, redefines pain management after surgery as an opioid-free alternative indicated for single-dose infiltration into the surgical site to produce postsurgical analgesia. Read More The company was founded in December 2006 and is headquartered in Parsippany, NJ.

Employees
518
Headquarters
Parsippany, New Jersey
Founded
2006
Market Cap
1.65B
Price-Earnings Ratio
228.02
Dividend Yield
0.00
Average Volume
443.57K
High Today
$39.88
Low Today
$39.11
Open Price
$39.88
Volume
70.93K
52 Week High
$55.00
52 Week Low
$35.07

Collections

Technology
Health
Pharmaceutical
US
North America

PCRX Earnings

$0.01
$0.16
$0.32
$0.47
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
Actual
Expected Aug 8, Pre-Market
All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.